Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.

Pathol Oncol Res · 2022 · PMC9532522 · PMID 36213161

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

almost significantlyp = 0.052so close (0.05 < p ≤ 0.1)

In our study the level of CD86 was almost significantly higher in the ibrutinib sensitive group than in the control group ( p = 0.052).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.